Achieving Record Growth with Expansion into Arizona Healthcare Market
Hospital Updates

Record-making Partnerships: IntraCare Continues to Strengthen Presence in Arizona as Three More Clinics Sign on in December

IntraCare, a prominent Texas-based MSO, gained record growth in the month of December 2023 upon signing partnership agreements with three medical entities in Arizona. This adds another 16 care practitioners to IntraCare’s provider network. The strategic partnerships with Atembis, LLC; Sun Lake Family Physicians, LLC; and Family Practice Specialists are a significant step towards achieving IntraCare’s objective to own […]

AI Revolutionizing Healthcare
Device Digest

China Medical University Hospital (CMUH) in Taiwan Upgrades Smart Healthcare with Gen AI

China Medical University Hospital (CMUH) in Taiwan announced its collaboration with Google Cloud in mid-December 2023. Using Google Cloud’s generative AI technology, including MedLM, which is a large language model built on Med-PaLM 2, CMUH has developed a comprehensive “AI-assisted Physician” system which aims to assist healthcare professionals in disease diagnosis, treatment planning, patient education, and medical research, etc.  The collaboration […]

Woman undergoing lymphedema screening
Device Digest

New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients

ImpediMed, a pioneer in the field of medical technology, announced a significant advancement in the fight against breast cancer-related lymphedema, a common but often overlooked condition affecting breast cancer survivors. Leading medical journal eClinicalMedicine, part of The Lancet Discovery Science, recently published new clinical guidance advocating for early detection and prevention strategies, underscoring the validity and efficacy […]

Wasatch Biolabs DNA Methylation Sequencing Service Launch
Device Digest

Wasatch Biolabs Launches Proprietary Targeted DNA Methylation Sequencing Service for Researchers and Healthcare Providers

Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies’ laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers. The technique is amplification and bisulfite conversion free, effectively bypassing the most common limitations of targeted methylation analysis and enabling WBL to create custom methylation panels that target […]

"IPX203 Parkinson's Treatment"
Drug Updates

Amneal Announces Complete Response Resubmission for IPX203 New Drug Application

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”) today announced that it has provided a Complete Response resubmission to the U.S. Food and Drug Administration (FDA) for IPX203, a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules for the treatment of Parkinson’s disease (PD). The original NDA for IPX203 resulted in a Complete Response […]

"MYALEPTA Health Canada Approval"
Drug Updates

Chiesi Global Rare Diseases Announces Health Canada Approval of MYALEPTA™ (metreleptin for injection) for the Treatment of Patients with Lipodystrophy

 Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, is pleased to announce the Health Canada approval of MYALEPTA™ (metreleptin for injection). As an adjunct to diet, MYALEPTA is indicated as a replacement therapy to treat the complications of leptin […]

"SCY-247 Preclinical Data Presentation"
Digital Health News

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of preclinical efficacy data on its second generation fungerp candidate SCY-247. Dr. Ashraf Ibrahim, PhD, FAAM, FECCM, Professor of Medicine in the Division of Infectious Diseases at the David Geffen School of Medicine […]

Dr. Klaus Romero Appointed CEO of Critical Path Institute
Hospital Updates

Critical Path Institute Appoints Dr. Klaus Romero as CEO and Promotes Cécile Ollivier to Vice President of International Affairs

Critical Path Institute (C-Path) has appointed Klaus Romero, M.D., M.S., FCP, as its new Chief Executive Officer and has promoted Cécile Ollivier, M.S., from former Managing Director for Europe to Vice President of International Affairs. With an impressive tenure spanning more than 16 years at C-Path, Dr. Romero has held key positions within the organization, including Chief […]

Saransh Chaudhary, CEO of Venus Remedies, holding GMP certification.
Drug Updates

Venus Remedies gets coveted GMP certification from Libya

Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in the production of injectable pharmaceuticals, including oncology, antibiotic and anticoagulant medications. Mr. Saransh Chaudhary, CEO […]

Digital Health News

GM Modular successfully organised Blood Donation Drive ; A demonstration of their service to Mankind

GM Modular, India’s leading electrical solutions manufacturer for modern living, recently organised a successful Blood Donation Drive in collaboration with NayiUdaan Trust on January 12th 2024 in Mumbai from 10am to 5pm. This humanitarian effort inspired many individuals to donate blood and help save lives. The camp was conducted in 9 railway stations including Western […]